These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24565527)

  • 61. Discovering patterns in drug-protein interactions based on their fingerprints.
    Luo W; Chan KC
    BMC Bioinformatics; 2012 Jun; 13 Suppl 9(Suppl 9):S4. PubMed ID: 22901089
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predicting DNA binding protein-drug interactions based on network similarity.
    Wang W; Lv H; Zhao Y
    BMC Bioinformatics; 2020 Jul; 21(1):322. PubMed ID: 32689927
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In silico profiling of systemic effects of drugs to predict unexpected interactions.
    Yoo S; Noh K; Shin M; Park J; Lee KH; Nam H; Lee D
    Sci Rep; 2018 Jan; 8(1):1612. PubMed ID: 29371651
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
    Yee SW; Brackman DJ; Ennis EA; Sugiyama Y; Kamdem LK; Blanchard R; Galetin A; Zhang L; Giacomini KM
    Clin Pharmacol Ther; 2018 Nov; 104(5):803-817. PubMed ID: 29679469
    [TBL] [Abstract][Full Text] [Related]  

  • 65. TarPred: a web application for predicting therapeutic and side effect targets of chemical compounds.
    Liu X; Gao Y; Peng J; Xu Y; Wang Y; Zhou N; Xing J; Luo X; Jiang H; Zheng M
    Bioinformatics; 2015 Jun; 31(12):2049-51. PubMed ID: 25686637
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Computational modeling approaches to quantitative structure-binding kinetics relationships in drug discovery.
    De Benedetti PG; Fanelli F
    Drug Discov Today; 2018 Jul; 23(7):1396-1406. PubMed ID: 29574212
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systematic analysis of the associations between adverse drug reactions and pathways.
    Chen X; Wang Y; Wang P; Lian B; Li C; Wang J; Li X; Jiang W
    Biomed Res Int; 2015; 2015():670949. PubMed ID: 26495310
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inferring protein domain interactions from databases of interacting proteins.
    Riley R; Lee C; Sabatti C; Eisenberg D
    Genome Biol; 2005; 6(10):R89. PubMed ID: 16207360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Drug Target Protein-Protein Interaction Networks: A Systematic Perspective.
    Feng Y; Wang Q; Wang T
    Biomed Res Int; 2017; 2017():1289259. PubMed ID: 28691014
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Large-scale identification of adverse drug reaction-related proteins through a random walk model.
    Chen X; Shi H; Yang F; Yang L; Lv Y; Wang S; Dai E; Sun D; Jiang W
    Sci Rep; 2016 Nov; 6():36325. PubMed ID: 27805066
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Systems biology analysis of protein-drug interactions.
    Colinge J; Rix U; Bennett KL; Superti-Furga G
    Proteomics Clin Appl; 2012 Jan; 6(1-2):102-16. PubMed ID: 22213655
    [TBL] [Abstract][Full Text] [Related]  

  • 72. IntSide: a web server for the chemical and biological examination of drug side effects.
    Juan-Blanco T; Duran-Frigola M; Aloy P
    Bioinformatics; 2015 Feb; 31(4):612-3. PubMed ID: 25380960
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predicting new molecular targets for known drugs.
    Keiser MJ; Setola V; Irwin JJ; Laggner C; Abbas AI; Hufeisen SJ; Jensen NH; Kuijer MB; Matos RC; Tran TB; Whaley R; Glennon RA; Hert J; Thomas KL; Edwards DD; Shoichet BK; Roth BL
    Nature; 2009 Nov; 462(7270):175-81. PubMed ID: 19881490
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predicting Drug-Target Interactions With Multi-Information Fusion.
    Peng L; Liao B; Zhu W; Li Z; Li K
    IEEE J Biomed Health Inform; 2017 Mar; 21(2):561-572. PubMed ID: 26731781
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Investigating drug-target association and dissociation mechanisms using metadynamics-based algorithms.
    Cavalli A; Spitaleri A; Saladino G; Gervasio FL
    Acc Chem Res; 2015 Feb; 48(2):277-85. PubMed ID: 25496113
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modularity in protein complex and drug interactions reveals new polypharmacological properties.
    Nacher JC; Schwartz JM
    PLoS One; 2012; 7(1):e30028. PubMed ID: 22279562
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identifying genomic and developmental causes of adverse drug reactions in children.
    Becker ML; Leeder JS
    Pharmacogenomics; 2010 Nov; 11(11):1591-602. PubMed ID: 21121777
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systematic review of pharmacoeconomic studies of pharmacogenomic tests.
    Beaulieu M; de Denus S; Lachaine J
    Pharmacogenomics; 2010 Nov; 11(11):1573-90. PubMed ID: 21121811
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Prediction of network drug target based on improved model of bipartite graph valuation].
    Liu X; Lu P; Zuo X; Chen J; Yang H; Yang Y; Gao Y
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(2):125-9. PubMed ID: 22737836
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Screening of drug target proteins by 2D ligand matching approach.
    Feng J; Guo H; Wang J; Lu T
    Chem Biol Drug Des; 2014 Feb; 83(2):174-82. PubMed ID: 24034065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.